Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer

Biochemical and Biophysical Research Communications

Volumn 306, Issue 4, 2003, Pages 912-917

  Huang, Jen Ming ^a   Lin, Tsen Yin ^a   Chang, Donald ^a   Lin, Shi Lung ^a   Ying, Shao Yao ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Androgen independent; Apoptosis; Bcl 2; Bcl 2 ; In situ prostate cancer; Invasive prostate cancer cells; Laser capture microdissection; Metastasis; Microarray; Prostate cancer; RNA PCR

Indexed keywords

PROTEIN; PROTEIN BCL 2 PSI; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER GRADING; CANCER THERAPY; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0038434197     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01072-6     Document Type: Article

References (21)

1. Amanatullah D.F., Reutens A.T., Zafonte B.T., Fu M., Mani S., Pestell R.G. Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycle. Front. Biosci. 5:2000;372-390.
2. Howe H.L., Wingo P.A., Thun M.J., Ries L.A., Rosenberg H.M., Feigal E.G., Edwards B.K. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst. 93:2001;824-842.
3. Lee Y.F., Lin W.J., Huang J., Messing E.M., Chan F.L., Wilding G., Chang C. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyglutamide in androgen receptor-negative prostate cancer cells. Cancer Res. 62:2002;6039-6044.
4. McConkey D.J., Greene G., Pettaway C.A. Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res. 56:1996;5594-5599.
5. Tang D.G., Porter A.T. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate. 32:1997;284-293.
6. McDonnell T.J., Troncoso P., Brisbat S.M., Logothetis C., Chung L.W., Hsieh J.T., Tu S.M., Campbell M.L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52:1992;6940-6944.
7. Raffo A.J., Perlman H., Chen M.W., Day M.L., Streitman J.S., Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55:1995;4438-4445.
8. Ying S.Y., Lui H.M., Lin S.L., Chuong C.M. Generation of full-length cDNA library from single human prostate cancer cells. Biotechniques. 27:1999;410-414.
9. Lin S.L., Chuong C.M., Widelitz R.B., Ying S.Y. In vivo analysis of cancerous gene expression by RNA-polymerase chain reaction. Nucleic Acid Res. 27:1999;4585-4589.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
11. Adens P.D., Ohh M. Identification of associated proteins by coimmunoprecipitation. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual. third ed. 2001;18.60-18.68 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. Merrifield R.B. Automated synthesis of peptides. Science. 150:1965;178-185.
13. Ling N., Esch F., Bohlen P., Brazeau P., Wehrenberg W.B., Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc. Natl. Acad. Sci. USA. 81:1984;4302-4306.
14. Cuevas P., Ying S.Y., Ling N., Ueno N., Esch F., Guillemin R., Healy D., Ta S. Immunohistochemical detection of inhibin in the gonad. Biochem. Biophys. Res. Commun. 142:1987;23-30.
15. Lin S.L. Peptide library construction from RNA-PCR-derived RNAs. Methods Mol. Biol. 221:2003;289-293.
16. Zha H., Aime-Sempe C., Sato T., Reed J.C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271:1996;7440-7444.
17. Tsujimoto Y., Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 466:2000;6-10.
18. Nowell P.C. The clonal evolution of tumor cell populations. Science. 194:1976;23-28.
19. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
20. Aaltonen L.A., Peltomaki P., Leach F.S., Sistonen P., Pylkkanen L.et al. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-816.
21. Uchida T., Wada C., Wang C., Ishida H., Egawa S., Yokoyama E., Ohtani H., Koshiba K. Microsatellite instability in prostate cancer. Oncogene. 10:1995;1019-1022.